CXCL10

CXCL10
Dostupne strukture
PDBPretraga ortologa: PDBe RCSB
Spisak PDB ID kodova

1O80, 1LV9, 1O7Y, 1O7Z

Identifikatori
AliasiCXCL10
Vanjski ID-jeviOMIM: 147310 MGI: 1352450 HomoloGene: 1203 GeneCards: CXCL10
Lokacija gena (čovjek)
Hromosom 4 (čovjek)
Hrom.Hromosom 4 (čovjek)[1]
Hromosom 4 (čovjek)
Genomska lokacija za CXCL10
Genomska lokacija za CXCL10
Bend4q21.1Početak76,021,118 bp[1]
Kraj76,023,497 bp[1]
Lokacija gena (miš)
Hromosom 5 (miš)
Hrom.Hromosom 5 (miš)[2]
Hromosom 5 (miš)
Genomska lokacija za CXCL10
Genomska lokacija za CXCL10
Bend5 E2|5 46.57 cMPočetak92,494,497 bp[2]
Kraj92,496,748 bp[2]
Obrazac RNK ekspresije
Više referentnih podataka o ekspresiji
Ontologija gena
Molekularna funkcija cytokine activity
heparin binding
CXCR3 chemokine receptor binding
chemokine activity
GO:0001948, GO:0016582 vezivanje za proteine
cAMP-dependent protein kinase regulator activity
signaling receptor binding
chemoattractant activity
Ćelijska komponenta extracellular region
external side of plasma membrane
Vanćelijsko
intracellular anatomical structure
Biološki proces regulation of endothelial tube morphogenesis
negative regulation of myoblast differentiation
cellular response to heat
response to vitamin D
positive regulation of cell migration
T cell chemotaxis
chemokine-mediated signaling pathway
cell-cell signaling
response to virus
muscle organ development
positive regulation of monocyte chemotaxis
positive regulation of release of sequestered calcium ion into cytosol
endothelial cell activation
positive regulation of cAMP-mediated signaling
regulation of T cell chemotaxis
Krvotok
Hemotaksija
positive regulation of leukocyte chemotaxis
cell surface receptor signaling pathway
response to lipopolysaccharide
negative regulation of myoblast fusion
defense response to virus
regulation of cell population proliferation
GO:0046730, GO:0046737, GO:0046738, GO:0046736 Imuni odgovor
positive regulation of cell population proliferation
response to auditory stimulus
negative regulation of angiogenesis
response to cold
cellular response to lipopolysaccharide
response to gamma radiation
positive regulation of T cell migration
GO:0072468 Transdukcija signala
GO:0003257, GO:0010735, GO:1901228, GO:1900622, GO:1904488 positive regulation of transcription by RNA polymerase II
regulation of protein kinase activity
defense response
inflammatory response
antimicrobial humoral immune response mediated by antimicrobial peptide
regulation of signaling receptor activity
G protein-coupled receptor signaling pathway
cytokine-mediated signaling pathway
adenylate cyclase-activating G protein-coupled receptor signaling pathway
response to bacterium
neutrophil chemotaxis
leukocyte chemotaxis
positive chemotaxis
regulation of apoptotic process
Izvori:Amigo / QuickGO
Ortolozi
VrsteČovjekMiš
Entrez
Ensembl
UniProt
RefSeq (mRNK)

NM_001565

NM_021274

RefSeq (bjelančevina)

NP_001556

NP_067249

Lokacija (UCSC)Chr 4: 76.02 – 76.02 MbChr 5: 92.49 – 92.5 Mb
PubMed pretraga[3][4]
Wikipodaci
Pogledaj/uredi – čovjekPogledaj/uredi – miš

Hemokinski ligand 10 (C-X-C motv) (CXCL10), znan i kao interferonom gama inducirani protein 10 (IP-10) ili maloinducibilni citokin B10 jest citokinski protein od 8,7 kDa, koji je kod ljudi kodiran genom CXCL10 sa hromosoma 4.[5][6] C-X-C motiv hemokin 10 je mali citokin u porodici hemokina CXC.

Aminokiselinska sekvenca

[uredi | uredi izvor]

Dužina polipeptidnog lanca je 98 aminokiselina, а molekulska težina 10.881 Da.[7]

1020304050
MNQTAILICCLIFLTLSGIQGVPLSRTVRCTCISISNQPVNPRSLEKLEI
IPASQFCPRVEIIATMKKKGEKRCLNPESKAIKNLLKAVSKERSKRSP

Struktura

[uredi | uredi izvor]

Trodimenzijska kristalna struktura ovog hemokina određena je pod tri različita uslova do rezolucije do 1,92Å.[8] Pristupni kodovi Proteinske banke podataka za strukture CXCL10 su 1lv9, 1o7y i 1o80.

Funkcija

[uredi | uredi izvor]

CXCL10 se izlučuje u nekoliko tipova ćelija, kao odgovor na IFN-γ. Ovi tipovi ćelija uključuju monocite, endotelne ćelije i fibroblaste.[5] Pripisuje mu se nekoliko uloga, kao što je hemoatrakcija za monocite / makrofage, T-ćelije, NK-ćelije i dendritske ćelije, promocija adhezije T-ćelija na endotelne ćelije, antitumorske aktivnosti i inhibicije formiranja kolonija koštane srži i angiogeneze.[9][10] Ovaj hemokin izaziva svoje efekte vezivanjem za hemokinske receprtore CXCR3 na površini ćelije.[11]

Biomarkeri

[uredi | uredi izvor]

CXCL9, CXCL10 i CXCL11 su se pokazali kao valjani biomarkeri za razvoj srčane insuficijencije i disfunkcije lijeve komore, što ukazuje na potcrtavajući patofiziološki odnos između nivoa ovih hemokina i razvoja nepovoljnog remodeliranja srca.[12] [13]

Klinički značaj

[uredi | uredi izvor]

Osnovni nivoi CXCL10 u plazmi prije tretmana su povišeni kod pacijenata hronično inficiranih virusom hepatitisa C (HCV) genotipova 1 ili 4 koji ne postižu trajni virusni odgovor (SVR) nakon završetka antivirusne terapije.[14][15] CXCL10 u plazmi sispoljava se u svojoj unutarjetrenoj iRNK, a oboje upečatljivo predviđaju prve dane eliminacije HCV RNK („opadanje prve faze“) tokom terapije interferonom/ribavirinom za sve HCV genotipove.[16] Ovo se također odnosi na pacijente koinficirane HIV-om, gdje nivoi IP-10 prije tretmana ispod 150 pg/mL predviđaju povoljan odgovor i stoga mogu biti korisni u ohrabrivanju ovih inače teško liječivih pacijenata da započnu terapiju.[17] Patogen Leishmania major ima proteazu, GP63, koja cijepa CXCL10, implicirajući CXCL10 u odbrambene mehanizme domaćina određenih unutarćelijskih patogena, poput Leishmania.[18]

Reference

[uredi | uredi izvor]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000169245 - Ensembl, maj 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000034855 - Ensembl, maj 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b Luster AD, Unkeless JC, Ravetch JV (1985). "Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins". Nature. 315 (6021): 672–6. Bibcode:1985Natur.315..672L. doi:10.1038/315672a0. PMID 3925348. S2CID 4358066.
  6. ^ Luster AD, Jhanwar SC, Chaganti RS, Kersey JH, Ravetch JV (maj 1987). "Interferon-inducible gene maps to a chromosomal band associated with a (4;11) translocation in acute leukemia cells". Proceedings of the National Academy of Sciences of the United States of America. 84 (9): 2868–71. Bibcode:1987PNAS...84.2868L. doi:10.1073/pnas.84.9.2868. PMC 304761. PMID 2437586.
  7. ^ "UniProt, P02778" (jezik: engleski). Pristupljeno 24. 10. 2021.
  8. ^ Swaminathan GJ, Holloway DE, Colvin RA, Campanella GK, Papageorgiou AC, Luster AD, Acharya KR (maj 2003). "Crystal structures of oligomeric forms of the IP-10/CXCL10 chemokine". Structure. 11 (5): 521–32. doi:10.1016/S0969-2126(03)00070-4. PMID 12737818.
  9. ^ Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, Luster AD (april 2002). "IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking". Journal of Immunology. 168 (7): 3195–204. doi:10.4049/jimmunol.168.7.3195. PMID 11907072.
  10. ^ Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, et al. (juli 1995). "Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo". The Journal of Experimental Medicine. 182 (1): 155–62. doi:10.1084/jem.182.1.155. PMC 2192108. PMID 7540647.
  11. ^ Booth V, Keizer DW, Kamphuis MB, Clark-Lewis I, Sykes BD (august 2002). "The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions". Biochemistry. 41 (33): 10418–25. doi:10.1021/bi026020q. PMID 12173928.
  12. ^ Altara R, Gu YM, Struijker-Boudier HA, Thijs L, Staessen JA, Blankesteijn WM (2015). "Left Ventricular Dysfunction and CXCR3 Ligands in Hypertension: From Animal Experiments to a Population-Based Pilot Study". PLOS ONE. 10 (10): e0141394. Bibcode:2015PLoSO..1041394A. doi:10.1371/journal.pone.0141394. PMC 4624781. PMID 26506526.
  13. ^ Altara R, Manca M, Hessel MH, Gu Y, van Vark LC, Akkerhuis KM, et al. (august 2016). "CXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study". Journal of Cardiovascular Translational Research. 9 (4): 302–14. doi:10.1007/s12265-016-9703-3. PMID 27271043. S2CID 41188765.
  14. ^ Romero AI, Lagging M, Westin J, Dhillon AP, Dustin LB, Pawlotsky JM, et al. (oktobar 2006). "Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection". The Journal of Infectious Diseases. 194 (7): 895–903. doi:10.1086/507307. PMID 16960776.
  15. ^ Lagging M, Romero AI, Westin J, Norkrans G, Dhillon AP, Pawlotsky JM, et al. (decembar 2006). "IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection". Hepatology. 44 (6): 1617–25. doi:10.1002/hep.21407. PMID 17133471. S2CID 27733803.
  16. ^ Askarieh G, Alsiö A, Pugnale P, Negro F, Ferrari C, Neumann AU, et al. (maj 2010). "Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C". Hepatology. 51 (5): 1523–30. doi:10.1002/hep.23509. PMID 20186843. S2CID 205873437.
  17. ^ Falconer K, Askarieh G, Weis N, Hellstrand K, Alaeus A, Lagging M (decembar 2010). "IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV". Scandinavian Journal of Infectious Diseases. 42 (11–12): 896–901. doi:10.3109/00365548.2010.498019. PMID 20608766. S2CID 28542340.
  18. ^ Antonia AL, Gibbs KD, Trahair ED, Pittman KJ, Martin AT, Schott BH, et al. (2019). "Pathogen Evasion of Chemokine Response Through Suppression of CXCL10". Frontiers in Cellular and Infection Microbiology. 9: 280. doi:10.3389/fcimb.2019.00280. PMC 6693555. PMID 31440475.

Dopunska literatura

[uredi | uredi izvor]

Vanjskik linkovi

[uredi | uredi izvor]